April 27, 2014

SMIP004 Small Molecule Inhibitor of p27 Degradation in Prostate Cancer

This video describes the discovery and characterization of the antiprostate cancer agent SMIP004 which was partly funded by the NIH Roadmap program.

This page last reviewed on April 20, 2015